Opioid Analgesic Reduction Study
Key facts
- Who runs it
- Rutgers, The State University of New Jersey
- Where
- Ann Arbor, Baltimore, Chicago, Newark, and Rochester, United StatesSee the 5 sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 1,815 people enrolled
- Started
- 4 Jan 2021
- Ended
- 24 Dec 2023
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- opioid-containing analgesic
- two over-the-counter analgesics
- Record updated
- 31 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 26 criteriaShow less
Who can take part
- An individual must meet all of the following criteria to be eligible to participate in the study:
- Be able to understand the informed consent
- Provide signed and dated informed consent form
- Be able to understand all directions for data gathering instruments in English
- Be willing and able to comply with all study procedures and be available for the duration of the study
- Planning to undergo extraction of one or more partial or fully impacted mandibular 3rd molars
- Be 18 years or older
- Be in good general health as evidenced by medical history
- Women must agree to use one of the following methods of contraception while participating in this study:; contraceptive pill; intra-uterine device; condoms; abstinence
Who cannot take part
- Any prior respiratory effect of an opioid or other anesthetic drugs that required respiratory support postoperatively
- Currently taking any of the following medications:; CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), which may increase plasma concentrations of hydrocodone bitartrate and acetaminophen and prolong opioid adverse reactions, and which may cause potentially fatal respiratory depression; CNS depressants
- Prior participation in this study
- History of gastrointestinal bleeding and/or peptic ulcer
- History of renal disease (excluding kidney stones)
- History of hepatic disease
- History of bleeding disorder
- History of respiratory depression
- History of known allegoric reaction to ibuprofen, acetaminophen, hydrocodone, and/or anesthesia
- Consumes 3 or more alcoholic drinks every day and/or has a history of alcoholism
- History of drug or alcohol abuse
- Family history of drug or alcohol abuse in a first-degree relative
- Participants who self-report the following history will be excluded from participating:
- Active or untreated asthma
- Has had no more than one opioid prescription filled within the past 12 months
- Currently pregnant or lactating; Participants would also be excluded due to any additional criteria that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study which includes:
- Inability or refusal to provide informed consent
Where in United States
- University of MichiganAnn Arbor, United States
- University of MarylandBaltimore, United States
- University of Illinois at ChicagoChicago, United States
- Rutgers School of Dental MedicineNewark, United States
- University of RochesterRochester, United States
About the trial
What the trial wants to find out
The goal is to provide health care professionals, including dentists, with the best possible evidence for clinical decision making when deciding upon analgesics for acute post-surgical pain management, a double-blind, stratified randomized clinical trial will be conducted to test the hypothesis that a combination of over-the-counter non-opioid containing analgesics is at least as, if not more, effective (non-inferior) than the most commonly prescribed opioid analgesic. The impacted 3rd molar extraction model will be used due to the predictable severity of the post-operative pain and generalizability of results.
Read full original descriptionShow less
This double-blind, prospective, stratified, randomized pragmatic clinical trial will use the impacted 3rd molar extraction pain model.
The 2 groups in the trial
- OpioidExisting treatment, for comparison
Combination analgesic of hydrocodone 5mg/acetaminophen 300 mg and a placebo pill.
Treatment: opioid-containing analgesic
- Non-OpioidExisting treatment, for comparison
Combination of ibuprofen 400 mg/acetaminophen 500 mg
Treatment: two over-the-counter analgesics
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Opioid Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain
- Record updated
- 31 August 2026